CDC accepts recommendations to update U.S. childhood immunization schedule after White House review request
The CDC said it accepted recommendations from a scientific assessment comparing U.S. childhood vaccination practices with peer nations, following a presidential directive to review international approaches. Federal health leaders said insurance coverage for currently recommended vaccines would remain in place while implementation moves forward.
A federal review triggers changes to how the schedule is organized
The Centers for Disease Control and Prevention announced on January 5, 2026 that it accepted recommendations from a comprehensive assessment of U.S. childhood immunization practices, conducted after President Donald Trump directed federal health agencies to review vaccination schedules used in peer, developed countries. The CDC statement said a decision memorandum was signed by Jim O’Neill, identified as Deputy Secretary of Health and Human Services serving as Acting CDC Director, formally accepting the recommendations and directing the agency to proceed with implementation.
The assessment, as described by the CDC, compared U.S. recommendations with those used by 20 peer nations, evaluated evidence and knowledge gaps, and examined issues such as public trust and the structure of mandates. The announcement said the U.S. is an outlier among developed nations in the number of diseases addressed and the total number of recommended doses, while not necessarily achieving higher vaccination rates than peer countries. Officials framed the policy shift as a move toward a more “focused” schedule intended to protect against serious infectious diseases while improving clarity and adherence.
Coverage and access remain a central reassurance
Federal leaders emphasized that vaccines currently recommended by the CDC would remain covered by insurance without cost-sharing, and that families would not lose access. The CDC release also said the updated schedule would continue to be organized into three categories: immunizations recommended for all children; immunizations recommended for certain high-risk groups or populations; and immunizations based on shared clinical decision-making. The announcement listed vaccines expected in the “all children” category, including protections for measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Hib, pneumococcal disease, HPV, and varicella.
The CDC also pointed to declining trust in health institutions and falling childhood vaccination rates in recent years as part of the context. It said federal agencies would work with states, physician groups, and other partners on implementation and parent and clinician education. The statement additionally called for more “gold standard” science, including randomized trials and long-term observational studies, to continuously evaluate benefits, risks, and outcomes as new data emerge.
- Announcement date: January 5, 2026.
- CDC said insurance coverage without cost-sharing would remain for currently recommended vaccines.
- Schedule remains organized into three categories, including shared clinical decision-making for some immunizations.